Pharma
Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, describes the company's AI-enabled software to detect illicit diversion of controlled and non-controlled substances in patient care and the use of AI in its wider portfolio.
The company will use the funds to create and launch new products, expand its network and speed up its growth.
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.
The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.
The company was founded by former Google DeepMind and Owkin scientists.
TenAces will develop an AI platform to help identify protein interactions that naturally occur in the body to assist with targeted protein degradation.
One Medical providers will be able to request drug consultations on complex medication regimens for seniors managing chronic conditions.
HIMSS24
HIMSS CEO Hal Wolf provides a sneak peek at what is in store for the thousands of HIMSS24 attendees in Orlando, the enhanced content for the event and how the company's recent partnership with Informa Markets is shaping the experience.
The proposed class action lawsuit alleges the pharmacy benefit manager worked with rival PBMs to exert its influence in the market and fix reimbursement rates and fees.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.